Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma

Checkpoint kinase 1 (CHK1) is an integral component of the cell cycle as well as the DNA Damage Response (DDR) pathway. Previous work has demonstrated the effectiveness of inhibiting CHK1 with small-molecule inhibitors, but the role of CHK1 mediated DDR in medulloblastoma is unknown. CHK1, both at t...

Descripción completa

Detalles Bibliográficos
Autores principales: Prince, Eric W., Balakrishnan, Ilango, Shah, Monil, Mulcahy Levy, Jean M., Griesinger, Andrea M., Alimova, Irina, Harris, Peter S., Birks, Diane K., Donson, Andrew M., Davidson, Nathan, Remke, Marc, Taylor, Michael D., Handler, Michael H., Foreman, Nicholas K., Venkataraman, Sujatha, Vibhakar, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288228/
https://www.ncbi.nlm.nih.gov/pubmed/27449089
http://dx.doi.org/10.18632/oncotarget.10692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288228/
https://www.ncbi.nlm.nih.gov/pubmed/27449089
http://dx.doi.org/10.18632/oncotarget.10692

Ejemplares similares